Cochrane Abstracts
Fluorine‐18‐fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Fluorine‐18‐fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) Computed Tomography (CT) for the Detection of Bone, Lung, and Lymph Node Metastases in Rhabdomyosarcoma." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438381/all/Fluorine‐18‐fluorodeoxyglucose__FDG__positron_emission_tomography__PET__computed_tomography__CT__for_the_detection_of_bone__lung__and_lymph_node_metastases_in_rhabdomyosarcoma.
Fluorine‐18‐fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438381/all/Fluorine‐18‐fluorodeoxyglucose__FDG__positron_emission_tomography__PET__computed_tomography__CT__for_the_detection_of_bone__lung__and_lymph_node_metastases_in_rhabdomyosarcoma. Accessed March 26, 2025.
Fluorine‐18‐fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438381/all/Fluorine‐18‐fluorodeoxyglucose__FDG__positron_emission_tomography__PET__computed_tomography__CT__for_the_detection_of_bone__lung__and_lymph_node_metastases_in_rhabdomyosarcoma
Fluorine‐18‐fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) Computed Tomography (CT) for the Detection of Bone, Lung, and Lymph Node Metastases in Rhabdomyosarcoma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438381/all/Fluorine‐18‐fluorodeoxyglucose__FDG__positron_emission_tomography__PET__computed_tomography__CT__for_the_detection_of_bone__lung__and_lymph_node_metastases_in_rhabdomyosarcoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Fluorine‐18‐fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma
ID - 438381
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438381/all/Fluorine‐18‐fluorodeoxyglucose__FDG__positron_emission_tomography__PET__computed_tomography__CT__for_the_detection_of_bone__lung__and_lymph_node_metastases_in_rhabdomyosarcoma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
